Angiotensin-converting enzyme 2 is an essential regulator of heart function - PubMed (original) (raw)
. 2002 Jun 20;417(6891):822-8.
doi: 10.1038/nature00786.
Renu Sarao, Gavin Y Oudit, Chana Yagil, Ivona Kozieradzki, Sam E Scanga, Antonio J Oliveira-dos-Santos, Joan da Costa, Liyong Zhang, York Pei, James Scholey, Carlos M Ferrario, Armen S Manoukian, Mark C Chappell, Peter H Backx, Yoram Yagil, Josef M Penninger
Affiliations
- PMID: 12075344
- DOI: 10.1038/nature00786
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Michael A Crackower et al. Nature. 2002.
Abstract
Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.
Comment in
- Two ACEs and a heart.
Bernstein KE. Bernstein KE. Nature. 2002 Jun 20;417(6891):799-802. doi: 10.1038/417799a. Nature. 2002. PMID: 12075331 No abstract available.
Similar articles
- Two ACEs and a heart.
Bernstein KE. Bernstein KE. Nature. 2002 Jun 20;417(6891):799-802. doi: 10.1038/417799a. Nature. 2002. PMID: 12075331 No abstract available. - A story of two ACEs.
Danilczyk U, Eriksson U, Crackower MA, Penninger JM. Danilczyk U, et al. J Mol Med (Berl). 2003 Apr;81(4):227-34. doi: 10.1007/s00109-003-0419-x. Epub 2003 Mar 28. J Mol Med (Berl). 2003. PMID: 12700890 Review. - Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M, Tatara Y, Shiota A, Sugano S, Takeda S, Rakugi H, Ogihara T. Yamamoto K, et al. Hypertension. 2006 Apr;47(4):718-26. doi: 10.1161/01.HYP.0000205833.89478.5b. Epub 2006 Feb 27. Hypertension. 2006. PMID: 16505206 - The role of ACE2 in cardiovascular physiology.
Oudit GY, Crackower MA, Backx PH, Penninger JM. Oudit GY, et al. Trends Cardiovasc Med. 2003 Apr;13(3):93-101. doi: 10.1016/s1050-1738(02)00233-5. Trends Cardiovasc Med. 2003. PMID: 12691672 Review. - Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.
Yang Z, Yu X, Cheng L, Miao LY, Li HX, Han LH, Jiang WP. Yang Z, et al. Arch Cardiovasc Dis. 2013 Apr;106(4):196-201. doi: 10.1016/j.acvd.2013.01.004. Epub 2013 Apr 10. Arch Cardiovasc Dis. 2013. PMID: 23706365
Cited by
- ACE2 Knockout Mice Are Resistant to High-Fat Diet-Induced Obesity in an Age-Dependent Manner.
Nunes-Souza V, Alenina N, Qadri F, Mosienko V, Santos RAS, Bader M, Rabelo LA. Nunes-Souza V, et al. Int J Mol Sci. 2024 Sep 1;25(17):9515. doi: 10.3390/ijms25179515. Int J Mol Sci. 2024. PMID: 39273464 Free PMC article. - Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2.
Xu W, Langhans SA, Johnson DK, Stauff E, Kandula VVR, Kecskemethy HH, Averill LW, Yue X. Xu W, et al. Int J Mol Sci. 2024 Aug 30;25(17):9419. doi: 10.3390/ijms25179419. Int J Mol Sci. 2024. PMID: 39273366 Free PMC article. Review. - Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
Tawengi M, Al-Dali Y, Tawengi A, Benter IF, Akhtar S. Tawengi M, et al. Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review. - A cross-sectional study on clinical characteristics and severity of children with COVID-19 admitted to a teaching institute in North India.
Nauriyal D, Dubey R, Agrawal P, Kumar D, Punj A, Nasser K. Nauriyal D, et al. J Family Med Prim Care. 2024 Jul;13(7):2653-2662. doi: 10.4103/jfmpc.jfmpc_1734_23. Epub 2024 Jun 28. J Family Med Prim Care. 2024. PMID: 39071009 Free PMC article. - Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).
Ueno A, Onishi Y, Mise K, Yamaguchi S, Kanno A, Nojima I, Higuchi C, Uchida HA, Shikata K, Miyamoto S, Nakatsuka A, Eguchi J, Hida K, Katayama A, Watanabe M, Nakato T, Tone A, Teshigawara S, Matsuoka T, Kamei S, Murakami K, Shimizu I, Miyashita K, Ando S, Nunoue T, Wada J. Ueno A, et al. BMJ Open Diabetes Res Care. 2024 May 30;12(3):e004237. doi: 10.1136/bmjdrc-2024-004237. BMJ Open Diabetes Res Care. 2024. PMID: 38816205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous